Methodology examined in public.
Voice2Evidence is informed by scientific work presented across forums where patient experience, HEOR, market access, and real-world evidence are debated — including ISPOR, AMCP, the World EPA Congress, and the Journal of Clinical Oncology.
Real-World Patient Voice at Scale: Can Social Media Listening Inform US Payer and Access Decisions?
A cross-disciplinary panel exploring the credibility, integration, ethical guardrails, and payer relevance of social media listening as a complementary patient-experience evidence stream.
Patient-voice evidence across therapy areas, geographies, and decision forums.
ISPOR 2026
Accepted Posters- 01
Social Media Conversations on GLP-1 Therapies for Obesity: Real-World Experiences and Treatment Narratives
- 02
Social Media Sentiment Toward Anti-Amyloid Therapies in Early Alzheimer's Disease: Implications for Real-World Evidence and Decision-Making
- 03
An Automated Social Media Listening Analysis of Conversations on CGRP Preventive Therapies in Migraine
- 04
Social Media Conversations on Immune Checkpoint Inhibitors: Treatment Experiences, Safety, Access, and Patient Perspectives
- 05
Real-World Online Conversations on MASH/NASH: A One-Year Social Media Listening Analysis
AMCP 2026
Accepted Poster- 01
Real-World Access and Affordability Barriers in Anal Cancer: Insights From a 5-Year Global Social Media Listening Study
World EPA Congress 2026
Accepted Poster- 01
Social Media Discussions of Probiotic Use in Irritable Bowel Syndrome (IBS): Real-World Use Patterns and Patient-Reported Experiences
Journal of Clinical Oncology
Publication- 01
Sociocultural and educational determinants of delayed diagnosis in anal cancer: Insights from a 5-year global social media analysis.
J Clin Oncol 44, 7 (2026)
Selected abstracts, posters, and panel details are available during briefing conversations where relevant to the asset, indication, or evidence question.
Tell us where you are in the lifecycle. We’ll show you what voice can become.
45-min strategic walkthrough · Confidential